POLY(BIS(2 2 2-TRIFLUOROETHOXY)PHOSPHAZ&
POLY(BIS(2 2 2-TRIFLUOROETHOXY)PHOSPHAZ& structure
|
Common Name | POLY(BIS(2 2 2-TRIFLUOROETHOXY)PHOSPHAZ& | ||
|---|---|---|---|---|
| CAS Number | 28212-50-2 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | (C4H4F6NPO2)n | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
| Name | Poly(bis(2,2,2-trifluoroethoxy)phosphazene) |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | (C4H4F6NPO2)n |
|---|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Properties and clinical development of a novel coating technology: the poly[bis(trifluoroethoxy)phosphazene].
Recent Pat. Drug Deliv. Formul. 4(1) , 18-22, (2010) Ultrapure poly[bis(trifluoroethoxy)phosphazene] is a novel biocompatible, anti-inflammatory, antithrombogenic polymer which has the potential to cover stent devices without elution of a cell cycle inh... |
|
|
A new polymer concept for coating of vascular stents using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis.
Invest. Radiol. 40(4) , 210-8, (2005) We sought to evaluate the new polymer PTFEP (poly(bis(trifluoroethoxy)phosphazene) for (1) its ability to reduce thrombogenicity and late in-stent stenosis and (2) its effect on endothelialization in ... |
|
|
The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.
Invest. Radiol. 42(5) , 303-11, (2007) Previous experimental studies have demonstrated that poly[bis(trifluoroethoxy)phosphazene] (PTFEP) nanocoated stents have antithrombotic characteristics, reduce in-stent stenosis, prevent wall inflamm... |
| MFCD06798815 |